• Home
• Partneringtools
• Reports

• In-licensing
• Out-licensing
• Companies

• Articles
• Events
• Outsourcing

• Consulting
• Jobs
• Forums

• About us
• Products
• Newsletter

Pharmalicensing Ltd
is a division of

News of the day

Industry news search

Recent news

To keep up to date with news from this category use our

Indevus Announces Private Placement of $105 Million of Non-Recourse Notes
LEXINGTON, Mass., August 26, 2008 -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced today that it has closed a private placement to institutional investors of $105.0 million of non-recourse notes (the "Notes")....

Cell Therapeutics, Inc. Announces Reverse Stock Split
SEATTLE, Aug 25, 2008 -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced that its Board of Directors has authorized a 1-for-10 reverse split of its common stock. The reverse split will become effective as...

Novo Nordisk A/S - Share repurchase programme
August 25, 2008 -- On 15 August 2008 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as...

Coloplast - first part of share buy-back programme finalised
August 25, 2008--As informed in Announcement No. 4/2008 the shareholders in general meeting in December 2007 authorised Coloplast to establish a share buy-back programme of up to DKK 1billion during 2008 and 2009.

PharmaGap Closes $1.1 million Public Portion of Anticipated $2.6 million Equity Financing; Announces Full Clinical Development Group to Take Lead Cancer Drug into Human Clinical Trials
Ottawa, Ontario/August 22, 2008 - PharmaGap Inc. (TSX-V: GAP) ("PharmaGap" or "the Company") today announced it has completed its previously announced offering of brokered equity securities for gross proceeds totaling...

Adaltis Announces Planned Cdn.$20 Million Private Placement of Senior Secured Convertible Notes
MONTREAL, QUEBEC--(Aug. 22, 2008) -Adaltis Inc. (TSX:ADS) ("Adaltis"), an international in vitro diagnostic company, today announced its intention to complete a private placement with Clarity China Partners, L.P. and...

ANGIOTECH ANNOUNCES EXTENSION OF THE EXPIRATION DATE OF ITS TENDER OFFER FOR SENIOR FLOATING RATE NOTES DUE 2013 AND 7.75% SENIOR SUBORDINATED NOTES DUE 2014n
VANCOUVER, BC, August 22, 2008 - Angiotech Pharmaceuticals, Inc. ("Angiotech") (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that in connection with the...

Hanger Orthopedic Group, Inc. Files Replacement Shelf Registration Statement
BETHESDA, Md., August 22, 2008 -- Hanger Orthopedic Group, Inc. (NYSE: HGR) announced today that it has filed a new shelf registration statement on Form S-3 with the Securities and Exchange Commission to sell, from time...

Columbia Laboratories Announces Registered Direct Common Stock Offering
LIVINGSTON, NJ-- August 22, 2008-- Columbia Laboratories, Inc. (Nasdaq: CBRX) today announced that it has priced a transaction to raise up to approximately $4.7 million through the sale of up to approximately 1.3...

Lupin Acquires Stake in Generic Health, Australia
August 21, 2008 -- Mumbai, India and Melbourne, Australia -- Lupin Ltd today announced that it has acquired a minority stake in Generic Health Pty Ltd, an Australian owned and operated generic pharmaceutical company...

BioSpecifics Technologies Corp. Announces Private Placement Offering
LYNBROOK, N.Y., Aug. 20 -- BioSpecifics Technologies Corp. (OTC Bulletin Board: BSTC -News), a biopharmaceutical company developing first in class collagenase based products, announced today that it raised an aggregate...

Lpath Closes $6.7 Million Equity Financing
SAN DIEGO, CA -- August 20, 2008 -- Lpath, Inc. (OTCBB: LPTN) The category leader in therapeutic agents against bioactive lipids, reported the receipt of approximately $6.7 million in gross proceeds in a private...

Zila Releases Preliminary Unaudited Financial Information
PHOENIX----Aug. 20, 2008--Zila, Inc. (NASDAQ:ZILA) today announced that, based on an unaudited, preliminary assessment, it has achieved positive adjusted EBITDA for its fiscal fourth quarter-ended July 31, 2008. The...

Ferro Corporation Announces Closing of Convertible Notes Offering and Early Acceptance of Tender Offer and Consent Solicitation for 9 1/8% Senior Notes
CLEVELAND-- August 19, 2008--Ferro Corporation (NYSE: FOE) (the "Company"), announced today the closing of its offering of $150 million aggregate principal amount of 6.50% Convertible Senior Notes due 2013 (the...

MEDAVANT WINS BANKRUPTCY COURT'S FINAL APPROVAL FOR $2.9 MILLION IN DIP FINANCING & APPROVAL OF OTHER PENDING MOTIONS
ATLANTA, GA.-- August 19, 2008--MedAvant Healthcare Solutions (MedAvant) (NASDAQ: PILLQ.PK), a leader in healthcare technology and transaction services, today announced that it won final approval from the United States...

Inflazyme Pharmaceuticals Ltd. (IZP.TO) Shareholders Approve Matters Necessary to Set New Direction and Completion of a $300,000 Non-Brokered Private Placement
VANCOUVER, BRITISH COLUMBIA--(August 19, 2008) - Inflazyme Pharmaceuticals Ltd., (NEX: IZP.H) today announced that at its AGM and Special Meeting, shareholders approved a number of resolutions that will allow the...

BioImagene, Inc. Raises $26 M in Expansion Capital
CUPERTINO, Calif.--August 19, 2008--BioImagene, the leading provider of affordable digital pathology solutions for cancer diagnosis and preclinical research, today announced the closing of a $26 million series D...

Acorda Therapeutics, Inc. Announces Exercise of Option by Underwriter
HAWTHORNE, N.Y.--Aug. 19, 2008--Acorda Therapeutics, Inc. (NASDAQ: ACOR) (the "Company") announced today that Deutsche Bank Securities Inc., as underwriter of the Company's common stock offering that was announced on...

F2G Ltd completes
Manchester, UK, 18th August 2008 - F2G Limited, the Manchester UK based antifungal drug discovery and development company, today announced the completion of a

iBioPharma, Inc. Announces Commencement of Trading On the OTC Bulletin Board
NEWARK, Del., August 18, 2008 -- iBioPharma, Inc. (OTCBB:IBPM) today announced that it began trading on the OTC Bulletin Board under the symbol "IBPM" subsequent to the completion of the spin-off from its former parent,...

Abiomed, Inc. Announces Common Stock Offering
DANVERS, Mass., Aug 18, 2008 -- Abiomed, Inc. (NASDAQ: ABMD) today announced the public offering of 2,419,932 shares of its common stock. Morgan Stanley & Co. Incorporated will be the sole underwriter for the offering.

Peplin secures approximately US$24m in additional financing
EMERYVILLE, California and BRISBANE, Australia, 18 August 2008: Peplin, Inc. (ASX:PLI) today announced the successful arrangement of a private placement of common stock and warrants to raise approximately US$24.0...

ABMC Completes Series A Debenture Offering
KINDERHOOK, N.Y.--Aug. 18, 2008--American Bio Medica Corporation (NASDAQ: ABMC) announced today that it has successfully completed its previously disclosed private placement of Series A Debentures. ABMC has accepted...

NOVELOS THERAPEUTICS CLOSES $3 MILLION PRIVATE PLACEMENT
NEWTON, Mass., August 18, 2008 - Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that it received $3...

Ba Research International Receives Investment from Summit Partners
HOUSTON & BOSTON -August 17 2005 - Ba Research International, a leading provider of generic analytical services for pharmaceutical companies worldwide, today announced it has received an investment from Summit Partners,...

Novo Nordisk A/S - Share repurchase programme
August 15, 2008 -- As part of the execution of Novo Nordisk's current DKK 17.5 billion share repurchase programme expected to be finalised before the end of 2009, a repurchase programme is initiated today in accordance...

ICON announces completion of "Stock Split"
Dublin, Ireland, August 14, 2008 - ICON (NASDAQ: ICLR) (ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that...

Corning Recommends Rejection of Below-Market Mini-Tender Offer by TRC Capital Corporation
CORNING, N.Y., August 14, 2008 - Corning Incorporated (NYSE:GLW) today said it has received notification of an unsolicited "mini-tender" offer by TRC Capital Corporation to acquire up to four million Corning shares from...

Novo Nordisk A/S purchases B shares worth DKK 1.0 billion from Novo A/S as part of the ongoing share repurchase programme
August 14, 2008 -- Novo Nordisk A/S has today acquired 3,304,800 B shares (nominal DKK 1), worth DKK 1.0 billion, from Novo A/S as part of the ongoing DKK 17.5 billion share repurchase programme for 2006-2009. The...

New Loan Agreement and Notice of Results
August 14, 2008 -- LiDCO Group Plc (AIM: LID), announces today that, as anticipated in the last annual report, it has replaced the Laurus loan facility. The Company has negotiated a

PharmaGap Files Final Prospectus for Issue of Equity Units and announces $1,555,395 Private Placement to SC Stormont Holdings
Ottawa, Ontario/August 14, 2008 - PharmaGap Inc. (TSX-V: GAP) ("PharmaGap" or "the Company") today announced that it has filed a final short form prospectus qualifying for sale a minimum of 6,666,667 and a maximum of...

ANTHERA PHARMACEUTICALS COMPLETES $19 MILLION FINANCING; APPOINTS CHRISTOPHER S. HENNEY AS CHAIRMAN
SAN MATEO, CA - August 13, 2008 - Anthera Pharmaceuticals Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs, today announced the completion of a $19 Million equity financing. New...

Ferro Corporation Prices Convertible Debt Offering
CLEVELAND-- August 13, 2008--Ferro Corporation (NYSE: FOE) (the "Company") announced today that it has priced a public offering of $150 million aggregate principal amount of its Convertible Senior Notes due 2013 (the...

BrainsGate raises $27.5M
August 13, 2008--CAESAREA, Israel - BrainsGate Ltd., a developer of an innovative therapeutic platform technology based on electrical neurostimulation of the Spheno-Palatine Ganglion, today announced the completion of a...

Questcor Repurchases 2.2 Million Common Shares From Chaumiere Consultadoria & Servicos SDC Unipessoal L.D.A.
UNION CITY, Calif., Aug. 13, 2008 -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that it has repurchased 2.2 million of its common shares from Chaumiere Consultadoria & Servicos SDC Unipessoal L.D.A....

China Medical Technologies Prices Concurrent Offerings of $240 Million of Convertible Senior Notes and Up To 4,700,000 Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements
BEIJING, Aug. 13 -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED) today announced the pricing of its public offerings of $240.0 million aggregate principal amount of convertible senior notes due 2013...

Opexa Therapeutics Completes $3 Million Financing
THE WOODLANDS, Texas--August 13, 2008--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing novel cell therapies for multiple sclerosis, today announced the completion of a private placement financing with total...

Placing
August 13, 2008-ReGen announces that due to market demand following the recent placing it has today placed, directly and through its broker 123,839 ordinary shares of 10p each at 16.15p per share ('the Placing') and as...

Illumina Announces Completion of Public Offering of Common Stock
SAN DIEGO-- August 12, 2008--Illumina, Inc. (NASDAQ:ILMN) today announced that the underwriter of the public offering of the Company's common stock fully exercised its option to purchase up to 525,000 additional shares....

Cannasat Therapeutics Announces Closing of Private Placement
TORONTO -August 12, 2008 Cannasat Therapeutics Inc. (CTH - TSXV) ("Cannasat") is pleased to announce that it has closed a non-brokered private placement (the "Private Placement") of units ("Units") effective August 8,...

Fresenius SE: successfully completes capital increase
August 12, 2008 -- The new Fresenius SE shares were successfully placed today. In connection with the company's capital increase, 2,748,057 new ordinary shares were issued at a price of EUR 52.00 and 2,748,057...

Signature Diagnostics Raised 5.1 Mio EURO in a Series C Financing Round
12 August 2008-Signature Diagnostics announced today the closing of a 5.1 million EURO series C financing round involving four financial investors from Germany and most of the existing A round investors.

Financing and Commercial Update
August 12, 2008-As announced by ReGen Therapeutics Plc ('ReGen' or the 'Company'), (AIM: RGT) on 14 September 2005, ReGen had entered into a £2,000,000 equity credit facility agreement with Headstart Group of Funds...

Ferro Corporation Announces $150 Million Convertible Debt Offering
CLEVELAND-- August 12, 2008--Ferro Corporation (NYSE: FOE) (the "Company") announced today that it is commencing an underwritten public offering of $150 million aggregate principal amount of convertible senior notes due...

NUCRYST Announces Share Repurchase Program
Wakefield, Massachusetts - August 12, 2008 - NUCRYST Pharmaceuticals, a developer and manufacturer of medical products that fight infection and inflammation, today announced that its Board of Directors has authorized a...

EpiCept Announces Pricing of Public Offering
TARRYTOWN, N.Y., August 11, 2008 -- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today the pricing of a public offering of approximately 5.2 million shares of its common stock at approximately...

XOFT SECURES $25 MILLION IN ADDITIONAL FUNDING FOR AWARD-WINNING ELECTRONIC BRACHYTHERAPY TECHNOLOGY
SUNNYVALE, Calif. - August 11, 2008 - Xoft, Inc., developer of Electronic Brachytherapy (eBx), a proprietary cancer treatment platform, announced today that the company has closed its Series E preferred stock financing,...

China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements
BEIJING, Aug. 11 -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED) today announced that it intends to offer, subject to market and other conditions, $150.0 million aggregate principal amount of...

Novo Nordisk A/S - Share repurchase programme
August 11, 2008 -- On 31 January 2008 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as...

Substantial oversubscription in first phase of syndication of US$ 2,400 million Senior Secured Credit Facilities
August 11, 2008 -- As a further component of the acquisition financing of APP Pharmaceuticals, Inc., US$ 2,400 million Senior Secured Credit Facilities were successfully offered in a first phase of syndication. Thereof,...

Solutia Prices Offering of 22,307,692 Shares At $13 Per Share
ST. LOUIS, Aug. 11, 2008 -- Solutia Inc. (NYSE:SOA) today announced the pricing of an underwritten public offering of 22,307,692 shares of its common stock at a price of $13 per share for gross proceeds of approximately...

AkzoNobel share buyback program (week 32 of 2008)
August 11, 2008 - AkzoNobel has announced that, in line with the launch of its share buyback program on March 17, 2008, the company has repurchased 1,031,840 ordinary shares in the period August 4 until August 8, 2008....

Cytori to Raise $17 Million in Private Placement with Olympus and Institutional Investors
SAN DIEGO, Aug 08, 2008-- Cytori Therapeutics (NASDAQ: CYTX) is to raise approximately $17 million from a private placement financing led by Olympus Corporation (TSE: 7733) with participation from select institutional...

Investors Led by The Frost Group Agree to Make $15 Million Investment in OPKO Health
MIAMI, Aug 08, 2008 -- OPKO Health, Inc. (AMEX:OPK) today announced that a group of investors led by members of The Frost Group, a private investment group controlled by Dr. Phillip Frost, M.D., Chairman and CEO of...

Lorus Therapeutics Successfully Completes Rights Offering, Raising $3.71 Million
TORONTO, CANADA, August 8, 2008 - Lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus"), a biopharmaceutical company specializing in the research and development of pharmaceutical products and technologies for the...

Med BioGene Completes First Tranche of Financing
August 07, 2008 -- VANCOUVER, BRITISH COLUMBIA - Med BioGene Inc. (TSX Venture: MBI), a life science company focused on the development and commercialization of genomic-based diagnostic tests for cancer and...

Celleration® Completes $30 Million Financing
(Eden Prairie, MN) - August 7, 2008 - Celleration, Inc., developer of the patented MIST Therapy® System, an innovative ultrasound wound healing device that promotes healing through cellular stimulation while removing...

ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing
August 07, 2008 -- ESBATech AG, a leading developer of antibody fragment therapeutics, today announced that the company has raised an additional CHF 23M (USD 22M, EUR 14M) in an extended Series B venture round to expand...

Acorda Therapeutics, Inc. Announces Pricing of Common Stock Offering
HAWTHORNE, N.Y.-- August 7, 2008--Acorda Therapeutics, Inc. (NASDAQ: ACOR) (the "Company") announced today the pricing of a public offering of 4,000,000 shares of its common stock at $28.50 per share. The shares are...

Illumina Announces Pricing of its Public Offering of Common Stock
SAN DIEGO-- August 7, 2008--Illumina, Inc. (NASDAQ:ILMN) today announced the pricing of its public offering of 3,500,000 shares of common stock at a public offering price of $87.50 per share, resulting in estimated net...

DiaMedica Closes $1.8 Million Financing
WINNIPEG, Manitoba - August 7, 2008 - DiaMedica Inc. (TSX-V:DMA) ("DiaMedica" or the "Company"), a drug discovery and development company focused on novel treatments for Type 2 diabetes, today announces that it has...

Achillion Announces Private Placement Financing for up to $41.5 Million
NEW HAVEN, Conn., Aug. 6, 2008 -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that...

Pluristem Therapeutics Announces $1.6 Million Securities Offering
NEW YORK--August 06, 2008--Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of...

Additional Listing
August 06, 2008 -- Cyprotex PLC (AIM: CRX), the drug discovery, technology and information company, today announces that it has issued 50,000 new ordinary shares of 0.1p each ("new Ordinary Shares") pursuant to the...

Incyte Announces Closing of Public Offering of Common Stock
WILMINGTON, Del.-- August 6, 2008--Incyte Corporation (Nasdaq:INCY) today announced the closing of its public offering of 12,075,000 shares of its common stock at a price to the public of $9.00 per share, which includes...

Dyax Enters into $50 Million Agreement with Cowen Healthcare Royalty Partners
CAMBRIDGE, Mass.--Aug. 6, 2008--Dyax Corp. (NASDAQ: DYAX) announced today that it has entered into a $50 million loan agreement with Cowen Healthcare Royalty Partners, L.P. ("CHRP") secured by the Company's phage...

VIVUS Announces Closing of $65 Million Registered Direct Offering of Common Stock
MOUNTAIN VIEW, Calif., Aug 06, 2008 -- VIVUS, Inc. (NASDAQ: VVUS) announced today that it has consummated the previously announced registered direct offering of 8,365,508 shares of its common stock to a select group of...

Biofrontera AG placed a capital increase
Leverkusen, 5 August 2008 - The management of Biofrontera AG (ISIN: DE 0006046113) has, irrespective of the difficult financial markets, with approval of the supervisory board used authorized capital to increase the...

VIVUS Announces $65 Million Registered Direct Offering of Common Stock
MOUNTAIN VIEW, Calif.----Aug. 5, 2008--VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that it has entered into...

OraSure Technologies Announces $25 Million Share Repurchase Program
BETHLEHEM, Pa.----Aug. 5, 2008--OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced that its Board of Directors has approved a share repurchase program to acquire up to...

ACADIA Pharmaceuticals Secures Committed Equity Financing Facility
SAN DIEGO, Aug 05, 2008 -- ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous...

EPIX Pharmaceuticals Secures Committed Equity Financing Facility
LEXINGTON, Mass., August 05, 2008 -- EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient...

Clarient Announces $8 Million Accounts Receivable Financing Agreement With Gemino Healthcare Finance
ALISO VIEJO, Calif.--Aug. 5, 2008--Clarient, Inc. (Nasdaq:CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, today announced it...

EpiCept Announces Pricing of Public Offering
TARRYTOWN, N.Y., August 04, 2008 -- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today the pricing of a public offering of approximately 5.53 million shares of its common stock at $.5425 per...

AkzoNobel share buyback program (week 31 of 2008)
August 4, 2008 - AkzoNobel has announced that, in line with the launch of its share buyback program on March 17, 2008, the company has repurchased 1,946,721 ordinary shares in the period July 28 until August 1 2008....

InteKrin Therapeutics Announces $20 Million Series C Financing
Los Altos, California- Monday August 4, 2008 -- InteKrin Therapeutics, Inc., a clinical stage biopharmaceutical company focused on the development of products for diabetes, metabolism and obesity today announced it has...

Proposed Buyback of Equity Shares
August 04, 2008 -- "This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, August 12, 2008 at the Corporate Office of the Company at Mumbai to consider the Buy...

Novo Nordisk A/S - Share repurchase programme
August 04, 2008 -- On 31 January 2008 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as...

BioPhausia's extraordinary shareholders' meeting approved the rights issue 2:1 at an issue price of SEK 1.35 per share
August 04, 2008--BioPhausia's Extraordinary Shareholders' Meeting today approved the Board of Director's decision resolved on July 1 and 31, 2008 regarding the rights issue in BioPhausia. According to the terms of the...

Illumina Announces 3.5 Million Share Public Offering
SAN DIEGO-- August 4, 2008--Illumina, Inc. (NASDAQ:ILMN) today announced that it has filed a preliminary prospectus supplement to a shelf registration statement with the Securities and Exchange Commission relating to a...

BioCancell Completes $3.65 Million Fundraising Round
Jerusalem, Israel -August 3, 2008- BioCancell Therapeutics, Inc. (TASE:BICL) today announced the receipt of a $3.65 million investment from Tikcro Technologies Ltd, Clal Biotechnology Industries Ltd, and the Provident...

Taisho to Repurchase Treasury Stock on the Open Market (Treasury stock repurchase based on the Articles of Incorporation as stipulated by Article 165, Paragraph 2 of the Japanese Corporation Act)
August 01, 2008-Taisho Pharmaceutical Co., Ltd. has announced that it has repurchased treasury stock on the open market, as detailed below. This repurchase was based on the provisions of Article 156 of the Japanese...

Protagen closes new round of financing to strengthen technology position for novel diagnostics
August 01, 2008-Dortmund, Germany and New Jersey, USA, August 1, 2008: Protagen AG, a leading provider of GMP compliant protein analytical services, protein bioinformatics, and protein biochips announces the closing of...

NxStage Completes Final Closing of Previously Announced Private Placement of Common Stock
LAWRENCE, Mass., August 1, 2008 -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, announced today that it has completed its previously announced $43 million private...

NUVO ANNOUNCES PROPOSED AMENDMENTS TO OUTSTANDING CONVERTIBLE DEBENTURES
Mississauga, Ontario, Canada - August 1, 2008 - Nuvo Research Inc. (TSX: NRI), a Canadian drug development company focused on the research and development of drug products delivered to and through the skin using its...

NOVAVAX ANNOUNCES CLOSING OF $18 MILLION REGISTERED DIRECT OFFERING
ROCKVILLE, MD (August 1, 2008) - Novavax Inc. (NASDAQ: NVAX) announced today that it has completed the previously announced registered direct equity financing of $18 million by issuing common stock and warrants (the...

NIR DIAGNOSTICS ANNOUNCES LOAN FINANCING
CAMPBELLVILLE, Canada, August 1, 2008 - NIR Diagnostics Inc. (the "Company") (TSX Venture: NID), an innovator in the development of handheld healthcare diagnostic devices, today announced that it has completed a loan...

WorldHeart Closes US$30 Million in Financing
OAKLAND, Calif., Aug. 1, 2008 -- (Nasdaq: WHRT) World Heart Corporation ("WorldHeart") today announced that it completed a US$30 million private placement transaction and recapitalization previously announced under the...

ViRexx Announces Approvals of Rights Offering
EDMONTON, ALBERTA-- Aug. 1, 2008 - ViRexx Medical Corp. (TSX:VIR) (AMEX:REX) ("ViRexx"), a company focused on developing innovative-targeted therapeutic products that offer better quality of life and a renewed hope for...

Aeolus Pharmaceuticals Completes Senior Convertible Debt Financing
LAGUNA NIGUEL, CA, August 1, 2008 -- Aeolus Pharmaceuticals, Inc. (OTC Bulletin Board: AOLS), today announced that it has raised $500,000 through the sale of newly issued Senior Convertible Notes and warrants to...

Rockeby drawdown notice under standby subscription agreement
31 July 2008 -- Rockeby biomed Limited "Rockeby" (ASX:RBY) is pleased to announce the third drawdown notice under the standby subscription agreement between Rockeby and Fortrend Securities Pty LTd entered into on 5...

Incyte Announces Pricing of Public Offering of 10,500,000 Shares of Common Stock
WILMINGTON, Del.-- July 31, 2008--Incyte Corporation (Nasdaq:INCY) today announced the pricing of its underwritten public offering of 10,500,000 shares of its common stock at a price to the public of $9.00 per share....

Exchange ratio and subscription price set for the rights issue in BioPhausia - 2:1 and SEK 1.35 Respectively
July 31, 2008--The Board of Directors of BioPhausia AB (publ) has today set the exchange ratio and subscription price for BioPhausia's rights issue that was resolved on July 1, 2008 by the Board of Directors, subject to...

Dr. Reddy's Laboratories Limited invests in Perlecan Pharma Private Limited by acquiring shares of Joint Venture Partners
Hyderabad, India, July 30, 2008: Dr. Reddy's Laboratories Ltd. (NYSE: RDY) today announced that it has purchased the equity holding of Citigroup Venture Capital International Mauritius Limited (CVCIML), its nominees and...

Novogen raises A$5.5m for investment in Marshall Edwards
July 30, 2008 -- Sydney Australia : Novogen Limited (ASX: NRT; NASDAQ: NVGN) has raised A$5.5million in an equity issue to substantial shareholder El Coronado Holdings LLC at A$1.22 per share. This issue is at a premium...

PSS World Medical Announces Pricing of Offering of $200 Million of Convertible Senior Notes
JACKSONVILLE, Fla., Jul 30, 2008 -- PSS World Medical, Inc. (NASDAQ GS: PSSI) announced today the pricing of a private placement of $200 million aggregate principal amount of 3.125% convertible senior notes due 2014 to...

MedMira Announces Completion of Equity Line Draw Down
Halifax, Nova Scotia, July 30, 2008 - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a global market leader in premium rapid diagnostic solutions, announced today that is has completed the draw down...

Industry news: Pharmalicensing provides comprehensive industry coverage.

Products:	Partnering Consulting	Partnering Search	Company Profiling	Comparision	Partneringtools	Reports
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Outsourcing
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search	Add your event
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic	Post your article
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Company releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us